OMED Stock Overview
Manufactures and sells medical devices in Indonesia, the United States of America, and South America. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
OMED passed our risk checks.
My Notes
Capture your thoughts, links and company narrative
PT Jayamas Medica Industri Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp178.00 |
| 52 Week High | Rp212.00 |
| 52 Week Low | Rp166.00 |
| Beta | -0.12 |
| 1 Month Change | -3.78% |
| 3 Month Change | 0.56% |
| 1 Year Change | -11.00% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -29.37% |
Recent News & Updates
Recent updates
Shareholder Returns
| OMED | ID Medical Equipment | ID Market | |
|---|---|---|---|
| 7D | -0.6% | -1.2% | -2.0% |
| 1Y | -11.0% | -2.5% | 2.1% |
Return vs Industry: OMED underperformed the ID Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: OMED underperformed the ID Market which returned 4.1% over the past year.
Price Volatility
| OMED volatility | |
|---|---|
| OMED Average Weekly Movement | 3.2% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in ID Market | 13.8% |
| 10% least volatile stocks in ID Market | 2.5% |
Stable Share Price: OMED has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: OMED's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 1,203 | Herlien Ariani | www.onemed.co.id |
PT Jayamas Medica Industri Tbk manufactures and sells medical devices in Indonesia, the United States of America, and South America. The company operates through three segments: Manufacturing, Distribution, and Retail. It offers medical disposables and consumables comprising medical gloves, syringes, masks, gauze, bandages, urine bag, foley catheter, alcoholic tissue, etc.; antiseptic and disinfectant fluids, povidone iodine, medical alcohol, Hdsol or blood cleansing liquid, etc.; and diagnostics and equipment, such as patient monitor, vital signs monitor, ECG reader, syringe pump, infusion pump, tensimeter, oxymeter, fingertip pulse etc. The company also provides walking aids and rehabilitation care products, including wheelchairs, crutches, walkers, arm slings etc.; biotechnology and laboratory products, such as pregnancy test, PCR test, blood collection tube, PCT tube, chemical reagents, etc; and hospital furniture products comprising patient bed, bed side cabinet, children’s patient bed, and operation lamp, as well as woundcare products which include plasters, cotton, sterile gauze, etc. It retails medical supplies and equipment through Medicom stores and online platforms.
PT Jayamas Medica Industri Tbk Fundamentals Summary
| OMED fundamental statistics | |
|---|---|
| Market cap | Rp4.82t |
| Earnings (TTM) | Rp287.90b |
| Revenue (TTM) | Rp1.84t |
16.7x
P/E Ratio2.6x
P/S RatioIs OMED overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMED income statement (TTM) | |
|---|---|
| Revenue | Rp1.84t |
| Cost of Revenue | Rp1.24t |
| Gross Profit | Rp599.80b |
| Other Expenses | Rp311.89b |
| Earnings | Rp287.90b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 10.64 |
| Gross Margin | 32.69% |
| Net Profit Margin | 15.69% |
| Debt/Equity Ratio | 6.7% |
How did OMED perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield27%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 08:27 |
| End of Day Share Price | 2025/02/06 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PT Jayamas Medica Industri Tbk is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Nicko Yosafat | PT Ciptadana Securities |
| Alif Ihsanario | PT Ciptadana Securities |